Global In-Vitro Diagnostics Sector - Prospects in Emerging Markets
May 2010
40
About the Report
About the Report
The present report on Global In-vitro diagnostics includes- market analysis, driving forces, industry competition and trends prevailing in the industry. Market analysis section talks about global in-vitro market size; major markets (United States comprise the largest market for IVD products, followed by Japan.) and market by players and sector. Section under IVD in United States, we have analyzed demand for IVD products in the country with the description of demand by product type and sector forecast. Also we have discussed demand in European Region and China. Growth drivers help to access the factors helping in the further growth and development of the sector. Further there are opportunities which may lead the industry growth in future. Also we have included industry trends and players profiling which gives a better understanding to the report.
- ;
- ;In the global health care industry, IVD sector is one of the most lucrative segments with a market size of US$~ billion globally in 2007, while the global IVD market generated sales of over US$~ billion in 2008. ;
- ;Point of care professional diagnostics market has a market size of around US$~ billion in 2008 and is growing at around 5% every year. ;
- ;In the global scenario, approximately 80% of the market is held by the top ten players, Roche being the biggest with a market share of ~%. Abbott is closely behind holding ~%. ;
- ;The costs of the IVD tests are declining due to improvement in the instruments, reagents and related consumables. ;
- ;Molecular diagnostics is becoming one of the dominant platforms of clinical laboratory medicine, representing one of the fastest growing segments in the IVD industry. ;
United States
- ;
- ;The demand for IVD products in United States is expected to reach US$~ billion in 2013 with an increase in the medical related activities, due to the aging demographic patterns, the volume of IVD testing procedures is bound to increase. ;
- ;In Clinical Chemistry there was an increase of 5.6% during 2003'2008, the demand for clinical chemistry IVD products reached US$~ billion in 2008. ;
- ;In Blood Testing, this segmentation witnessed a growth of 3.5% since 2003 and reached US$~ billion in 2008. ;
Europe
- ;
- ;The total European IVD market is valued at US$~ billion, growth was in the range of ~% versus 2007 (US$~ billion) and the market is expected to have a slow growth, which is attributed to the increase in the adoption of new technologies in the market. ;
- ;The market for IVDs in Austria is largely import oriented, with US having an import market share of ~% in 2007. ;
- ;Self test market drives the growth and is the most significant sector contributing to the market growth. ;
Products
Products
Clinical Chemistry, Near Patient Testing, Molecular diagnostics, Hematology, Immunology, Rapid Diagnostics, Microbiology, Applied Science, Blood Colle
Companies
Bayer AG, Roche, Johnson & Johnson, Siemens AG.
Table of Contents
Table of Contents
1. In-vitro Diagnostics Market
List of Figure
Figure 1: Global IVD Market and Forecast (2008&2010E)
Figure 2: IVD Market by Geography in 2007-2008
Figure 3: Geographical Sales of IVD in 2007
Figure 4: Market Share of Global IVD Players in 2009
Figure 5: Global IVD Market Share by Sector in 2007
Figure 6: Global IVD Market Share by Sector in 2010
Figure 7: In Vitro Demand (2000-2009)
Figure 8: In-Vitro Diagnostics by Product Type in United States (2009)
Figure 9: China IVD Market Size (2007 & 2008)
Figure 10: Point of Care Testing Segments in 2008
Figure 11: WW Aging Population within age group 55 to 80+ (1996-2010)
Figure 12: Urban per capita Disposable Income in China (1998-2007)
Figure 13: US Prevalence of COPD by Geographic regions in 2007
Figure 14: IVD Market Share by Company in 2008
Figure 15: Value of IVD Market in Poland (2004-2012E)
Figure 16: Polish IVD Market by Sector in 2008
Figure 17: Share of IVD Segments in India in 2008
Figure 18: Bayer Revenues by Business Segment in 2009
Figure 19: Roche Sales in Diagnostic Division (2007-2009)
Figure 20: J&J Net Sales (2005-2009)
List of Table
Table 1: In-Vitro Diagnostics Demand Forecast (2003, 2008 & 2013)
Table 2: IVD Market Statistics 2008
Table 3: In-Vitro Diagnostics Market (2007-2009)
Table 4: Population Aged between 65 Years Old for Selected Years
Table 5: The Japanese Market for IVDs and Medical Sample Testing Equipment in 2007
Table 6: Bayer Group Quarterly Sales (2008-2009)
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.